LADENBURG THALMANN FINANCIAL SERVICES INC. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$93,000
+9.4%
3,536
-5.4%
0.00%0.0%
Q3 2019$85,000
-12.4%
3,736
+18.0%
0.00%0.0%
Q2 2019$97,000
+120.5%
3,166
+18.8%
0.00%
Q1 2019$44,000
-13.7%
2,6660.0%0.00%
Q4 2018$51,000
-64.8%
2,666
-3.6%
0.00%
-100.0%
Q3 2018$145,000
+0.7%
2,766
-29.1%
0.00%0.0%
Q2 2018$144,0000.0%3,9000.0%0.00%0.0%
Q1 2018$144,000
+166.7%
3,900
+44.4%
0.00%0.0%
Q4 2017$54,000
-5.3%
2,700
+17.4%
0.00%0.0%
Q3 2017$57,0002,3000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders